Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Cell free fetal DNA might predict abnormal placental invasion
This study aims to evaluate whether measurement of cell-free fetal DNA in the maternal plasma can be predictive of abnormal invasion in cases of placenta previa.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Study group | Maternal plasma cell free fetal DNA levels will be measured in 25 women with one or more previous cesarean section and placenta previa anterior only or with ultrasound finding suggestive of placental adhesion or invasion (accreta , increta or percreta). |
| |
| Control group | Maternal plasma cell free fetal DNA levels will be measured in 25 matched control with normally situated placenta without ultrasound finding suggestive of placental adhesion or invasion. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Maternal plasma cell free fetal DNA levels | Diagnostic Test | Measurement Maternal plasma cell free fetal DNA levels in both groups (study and control groups) |
|
| Measure | Description | Time Frame |
|---|---|---|
| Predictive value of maternal plasma cell free DNA | Prediction of abnormal placental invasion in cases of placenta previa. Primary aim: Is to evaluate whether measurement of cell-free fetal DNA in the maternal plasma can be predictive of abnormal placental invasion in cases of placenta previa. Secondary aim: To decrease maternal morbidity and mortality by early prenatal diagnosis of abnormal placental invasion in placenta previa | 4 months |
| Measure | Description | Time Frame |
|---|---|---|
| maternal morbidity | maternal morbidity | 4 months |
Not provided
Inclusion criteria:
Exclusion criteria:
Multifetal pregnancy.
Hypertension, preterm labor and intrauterine growth restriction.
Patients taking a tocolytic agent or those with uterine bleeding at or after blood sampling.
Accidental hemorrhage.
Not provided
Not provided
Not provided
Study group (1): 25 women with one or more previous cesarean section and placenta previa anterior only or with ultrasound finding suggestive of placental adhesion or invasion (accreta , increta or percreta).
Not provided
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Ain Shams University, Maternity Hospital | Recruiting | Cairo | Egypt |
Not provided
| ID | Term |
|---|---|
| D010921 | Placenta Accreta |
| D010923 | Placenta Previa |
| ID | Term |
|---|---|
| D007744 | Obstetric Labor Complications |
| D011248 | Pregnancy Complications |
| D005261 | Female Urogenital Diseases and Pregnancy Complications |
| D000091642 | Urogenital Diseases |
Not provided
Not provided
Not provided
Not provided
Not provided
| D010922 | Placenta Diseases |